FLONASE SENSIMISTALLERGY RELIEF (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)


Welcome to the PulseAid listing for the FLONASE SENSIMIST drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
NON-PROPRIETARY NAME: fluticasone furoate
SUBSTANCE NAME: FLUTICASONE FUROATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-02-01
END MARKETING DATE: 0000-00-00


FLONASE SENSIMIST ALLERGY RELIEF HUMAN OTC DRUG Details:

Item DescriptionFLONASE SENSIMIST ALLERGY RELIEF from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
LABELER NAME: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 27.5(ug/1)
START MARKETING DATE: 2017-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0135-0615_40b990e2-8f01-4d95-ab14-dcfa624f92c6
PRODUCT NDC: 0135-0615
APPLICATION NUMBER: NDA022051

Other FLUTICASONE FUROATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline Consumer Healthcare Holdings (US) LLCFLONASE SENSIMIST
GlaxoSmithKline LLCVERAMYST
Physicians Total Care, Inc.Veramyst